BioCentury
ARTICLE | Clinical News

AspirinWorks: Additional Phase III data

October 27, 2008 7:00 AM UTC

A subgroup analysis of 3,261 aspirin-treated patients in the double-blind, placebo-controlled, international Phase III CHARISMA trial showed that patients with the highest quartile concentration of ur...